Crystec to present mSAS® technology at RSC conference

Crystec’s Development Director, Lyn Daintree, has been invited to speak at ‘Solubilising the insoluble: Formulation approaches’, an online event hosted by The Formulation Science & Technology (FST) interest group, part of the RSC (Royal Society of Chemistry).

The meeting is focused on formulation approaches to improve dissolution rates and solubility of poorly water-soluble actives. This is an area which is very much aligned with Crystec’s core capabilities, with the mSAS® (modified Supercritical Anti-Solvent) technology platform offering a range of strategies to address poor drug solubility.

Lyn’s talk, ‘In-particle design®: new mSAS® solutions to solubility challenges’ will be presented during the online event on Thursday 2nd December 2021. For more information, or to register to attend for free please visit www.formulation.org.uk/sti.html.

If you would like to learn more about how mSAS® can be applied to support your drug development programmes, please get in touch!